基本信息:
- 专利标题: MONOCLONAL ANTIBODIES THAT NEUTRALIZE ANTHRAX TOXINS
- 专利标题(中):中和毒素的单克隆抗体
- 申请号:PCT/US2008054609 申请日:2008-02-21
- 公开(公告)号:WO2008103845A3 公开(公告)日:2009-02-12
- 发明人: CHEN ZHAOCHUN , PURCELL ROBERT H , EMERSON SUZANNE U , LEPPLA STEPHEN H , MOAYERI MAHTAB
- 申请人: US GOV HEALTH & HUMAN SERV , CHEN ZHAOCHUN , PURCELL ROBERT H , EMERSON SUZANNE U , LEPPLA STEPHEN H , MOAYERI MAHTAB
- 专利权人: US GOV HEALTH & HUMAN SERV,CHEN ZHAOCHUN,PURCELL ROBERT H,EMERSON SUZANNE U,LEPPLA STEPHEN H,MOAYERI MAHTAB
- 当前专利权人: US GOV HEALTH & HUMAN SERV,CHEN ZHAOCHUN,PURCELL ROBERT H,EMERSON SUZANNE U,LEPPLA STEPHEN H,MOAYERI MAHTAB
- 优先权: US90302207 2007-02-23
- 主分类号: C07K16/12
- IPC分类号: C07K16/12
摘要:
The present invention relates to monoclonal antibodies that bind or neutralize anthrax lethal factor (LF), edema factor (EF), and/or protective antigen (PA). The invention provides such antibodies, fragments of such antibodies retaining anthrax toxin-binding ability, fully human or humanized antibodies retaining anthrax toxin-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Additionally, the invention provides for prophylactic, therapeutic, and diagnostic methods employing the antibodies and nucleic acids of the invention.
摘要(中):
本发明涉及结合或中和炭疽致死因子(LF),水肿因子(EF)和/或保护性抗原(PA)的单克隆抗体。 本发明提供了这样的抗体,这种抗体的保留了炭疽毒素结合能力的片段,完全人或人源化抗体,保留了炭疽毒素结合能力,以及包含这些抗体的药物组合物。 本发明还提供了编码本发明的抗体的分离的核酸和用其转化的宿主细胞。 另外,本发明提供了使用本发明的抗体和核酸的预防,治疗和诊断方法。
IPC结构图谱:
C | 化学;冶金 |
--C07 | 有机化学 |
----C07K | 肽 |
------C07K16/00 | 免疫球蛋白,例如,单克隆或多克隆抗体 |
--------C07K16/12 | .来自细菌的抵抗物质 |